Focus:
All articles by Allie Nawrat
-
FDA accepts Sarepta’s NDA for precision medicine Golodirsen
US precision medicine company Sarepta Therapeutics has announced the US Food and Drug Administration (FDA) has accepted its new drug…
15 Feb
Read More… -
Merck initiates three Phase III trials into Keytruda for prostate cancer
As a result of promising data from its Phase Ib/II KEYNOTE-365 trial, Merck has announced three new Phase III trials…
15 Feb
Read More… -
SK Biopharmaceuticals-Arvelle partner on epilepsy drug cenobamate in Europe
South Korea-based SK Biopharmaceuticals and Swiss Arvelle Therapeutics have signed an exclusive licensing agreement to develop and commercialise SK Biopharmaceuticals’…
14 Feb
Read More… -
Erectile dysfunction: giving patients more choice and better treatments
Many studies have found that sales of Viagra (sildenafil), a tablet used to treat erectile dysfunction in men, surge around…
14 Feb
Read More… -
AbCellera and Novartis enter into multi-target partnership
Canada-based AbCellera has announced it has signed a multi-year, multi-target agreement with Novartis under which its antibody discovery technology will…
14 Feb
Read More… -
National Heart Month: how can you heal a broken heart?
February has been designated as National Heart Month in both the UK and the US. National Heart Month aims to…
13 Feb
Read More… -
MHRA recalls a further three batches of sartan-based products
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has announced it has recalled three more batches of irbesartan as…
13 Feb
Read More… -
Dementia Consortium welcomes new partners to drug discovery collaboration
Charity industry partnership Dementia Consortium has announced that pharmaceutical companies, Johnson & Johnson Innovation, Takeda and research organisation Evotec have…
13 Feb
Read More… -
FDA grants Merck’s Keytruda priority review as first line therapy for HNSCC
Merck has announced the US Food and Drug Administration (FDA) has granted priority review for its supplementary biologics license application…
12 Feb
Read More… -
FDA clamps down on illegal dietary supplements
The US Food and Drug Administration (FDA) has announced new measures to strengthen its regulation and oversight of dietary supplements,…
12 Feb
Read More…
Go Top